Julie Milder, PhD

Julie leads Baszucki Group’s scientific initiatives. Throughout her career, she has applied her expertise in neuroscience across academia, grantmaking, scientific strategy and the pharmaceutical industry. Most recently, Julie was Associate Director at Jazz Pharmaceuticals where she led the US Medical Affairs Training and Excellence team to work collaboratively across multiple focus areas including epilepsy/movement disorders, sleep, hematology, and oncology. Prior to that, she served as the first scientist on staff for CURE Epilepsy, the largest non-governmental funder of epilepsy research where she directed their grantmaking and collaborative team science initiatives.

Julie is known throughout the epilepsy research and advocacy community for her passion and dedication to the cause. Her PhD focused on investigating the effects of a ketogenic diet on mitochondrial function and antioxidant response, given its utilization as a therapy for pediatric onset epilepsy. During her time at CURE Epilepsy, Julie initiated CURE Epilepsy’s first team science initiative, which sought to bring researchers and clinicians together to work toward a common goal of finding a new treatment for infantile spasms, a devastating epilepsy of infancy.

Julie received a PhD in Neuroscience from the University of Colorado, Denver and a BA in Biology/Neuroscience from Washington University in St. Louis. She lives in Denver with her two daughters and rescue dog, and they try to escape to the mountains as often as possible.